back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-08-18 11:24 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
95,263 | |
| Filed 2023-05-05 23:47 Tx date 2023-04-25 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+210,000 vol |
210,000 | |
| Filed 2023-05-05 23:45 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-27 13:06 Tx date 2022-07-25 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$35,000
+100,000 vol $0.35 each |
200,000 | |
| Filed 2022-07-27 13:03 Tx date 2022-07-25 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
-100,000 vol |
0 | |
| Filed 2022-07-27 12:58 Tx date 2021-06-23 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$35,000
+100,000 vol $0.35 each |
100,000 | |
| Filed 2022-07-27 12:56 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-27 12:56 Tx date 2021-06-23 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-35,000
-100,000 vol $0.35 each |
0 | |
| Filed 2022-07-27 12:54 Tx date 2021-06-23 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Warrants
90 - Change in the nature of ownership
|
+100,000 vol |
100,000 | |
| Filed 2022-07-27 12:50 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: ThriveDB Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-27 12:45 Tx date 2021-06-23 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Warrants
90 - Change in the nature of ownership
|
-100,000 vol |
0 | |
| Filed 2022-06-21 15:44 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,200
+30,000 vol $1.14 each |
65,263 | |
| Filed 2021-12-16 21:39 Tx date 2021-12-09 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+260,000 vol |
860,000 | |
| Filed 2021-10-04 18:36 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,496 vol |
48,948 | |
| Filed 2021-10-04 18:34 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
54 - Exercise of warrants
|
-8,134 vol |
0 | |
| Filed 2021-03-12 18:17 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
| Filed 2021-01-15 10:46 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+462 vol |
45,452 | |
| Filed 2021-01-15 10:43 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,239 vol |
8,134 | |
| Filed 2021-01-04 15:46 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,239 vol |
9,373 | |
| Filed 2020-12-02 16:08 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,713 vol |
44,990 | |
| Filed 2020-12-02 16:06 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
8,134 | |
| Filed 2020-10-05 19:51 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,428 vol |
43,277 | |
| Filed 2020-10-05 19:50 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-19,666 vol |
12,105 | |
| Filed 2020-10-05 19:50 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
31,771 | |
| Filed 2020-10-02 10:33 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,183 vol |
14,288 | |
| Filed 2020-09-24 12:47 Tx date 2020-09-22 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2020-09-24 12:43 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-24 12:42 Tx date 2020-09-22 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+100,000 vol $0.30 each |
100,000 | |
| Filed 2020-09-24 12:38 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-07 10:40 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,810 vol |
34,849 | |
| Filed 2020-07-07 10:38 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,810 vol |
12,105 | |
| Filed 2020-07-03 10:12 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,810 vol |
13,915 | |
| Filed 2020-05-01 11:05 Tx date 2019-10-29 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,864
+550 vol $3.39 each |
7,450 | |
| Filed 2020-05-01 11:03 Tx date 2019-10-28 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$23,048
+6,900 vol $3.34 each |
6,900 | |
| Filed 2020-05-01 11:01 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-06 16:42 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,212 vol |
33,039 | |
| Filed 2020-04-06 16:41 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,212 vol |
12,105 | |
| Filed 2020-04-02 10:02 Tx date 2020-03-31 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,212 vol |
14,317 | |
| Filed 2020-01-10 18:18 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,995.60
-14,000 vol $4.79 each |
30,827 | |
| Filed 2019-10-04 10:24 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+44,827 vol |
44,827 | |
| Filed 2019-10-04 10:23 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-04 10:22 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
12,105 | |
| Filed 2019-10-04 10:21 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
56,932 | |
| Filed 2019-09-18 10:30 Tx date 2019-09-13 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2019-09-18 10:30 Tx date 2019-04-26 |
$SVA
Sernova Corp. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-33,758 vol |
3,971 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,134 vol |
12,105 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
37,729 | |
| Filed 2017-12-04 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-09 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-09 Tx date 2017-11-07 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,499
+50,000 vol $0.57 each |
50,000 |